Ursula Vehling‐Kaiser

8.2k citations
107 papers · 2.3k · 1 hit paper · h-index 23

Impact in

  • Oncology top 1%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Cancer Treatment and Pharmacology
  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 47
    • Cancer Treatment and Pharmacology 16
    • Pancreatic and Hepatic Oncology Research 9
    • Lung Cancer Treatments and Mutations 16
    • Gastric Cancer Management and Outcomes 8

Ursula Vehling‐Kaiser

96 papers receiving 2.2k citations

Ursula Vehling‐Kaiser's Hit Papers

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer 2006 · 552 citations
5520+6+13Years since publication100200300400500

Peers

Ursula Vehling‐Kaiser
Comparison fields: 5 of 79
  • Oncology 1.6k
  • Hepatology 193
  • Cancer Research 349
  • Pathology and Forensic Medicine 321
  • Pulmonary and Respiratory Medicine 538
Replace Ludwig Fischer von Weikersthal with:
Ludwig Fischer von Weikersthal Germany
Michael A. Morse United States
Gina M. Vaccaro United States
Eiji Shinozaki Japan
Fabio Gelsomino Italy
Jean‐Luc Canon Belgium
Justin Kopit United States
James Biagi Canada
Olivier Dubreuil France
José María Viéitez Spain
Ursula Vehling‐Kaiser relative to Ludwig Fischer von Weikersthal Germany Ludwig Fischer von Weikersthal's profile →
Citations per field
00.5×1.5×
Ludwig Fischer von Weikersthal · 1×
Citations per year

Countries citing papers authored by Ursula Vehling‐Kaiser

Since Specialization
Citations

This map shows the geographic impact of Ursula Vehling‐Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Vehling‐Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Vehling‐Kaiser more than expected).

Fields of papers citing papers by Ursula Vehling‐Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ursula Vehling‐Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Vehling‐Kaiser. The network helps show where Ursula Vehling‐Kaiser may publish in the future.

Co-authors

The 25 scholars most cited alongside Ursula Vehling‐Kaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ursula Vehling‐Kaiser Line = papers co-authored together Ursula Vehling‐Kaiser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer
Hit paper breakdown →
2006552
2 2017100
3 201294
4 201493
5 201590
6 201190
7 201490
8 201382
9 201277
10 201475
11 200571
12 201348
13 201448
14 201443
15 201740
16 201340
17 201737
18 201834
19 201331
20 201527

About Ursula Vehling‐Kaiser

Ursula Vehling‐Kaiser is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Cancer Research, having authored 107 papers that have together received 2.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (47 papers), Cancer Treatment and Pharmacology (16 papers), Lung Cancer Treatments and Mutations (16 papers), Cancer Genomics and Diagnostics (12 papers), Palliative Care and End-of-Life Issues (10 papers), Pancreatic and Hepatic Oncology Research (9 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Gastric Cancer Management and Outcomes (8 papers). The work is most often cited by research in Oncology (1.6k citations), Hepatology (193 citations), Cancer Research (349 citations), Pathology and Forensic Medicine (321 citations) and Pulmonary and Respiratory Medicine (538 citations). Ursula Vehling‐Kaiser has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Volker Heinemann, Ludwig Fischer von Weikersthal, Sebastian Stintzing, Dominik Paul Modest, Andreas Jung, Thomas Decker, Thomas Kirchner, Tobias Heintges, Werner Scheithauer and Frank Kullmann. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, European Journal of Cancer and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact